Matrix metalloproteinase-2 in blood does not indicate the progression of prostate cancer
Open Access
- 29 October 1998
- journal article
- letter
- Published by Wiley in International Journal of Cancer
- Vol. 78 (3) , 392-393
- https://doi.org/10.1002/(sici)1097-0215(19981029)78:3<392::aid-ijc24>3.0.co;2-7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Kind of Sample as Preanalytical Determinant of Matrix Metalloproteinases 2 and 9 and Tissue Inhibitor of Metalloproteinase 2 in BloodClinical Chemistry, 1998
- Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extensionInternational Journal of Cancer, 1998
- Detection of prostate carcinoma using prostate specific antigen, its density, and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrationsCancer, 1997
- Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancerInternational Journal of Cancer, 1997
- Activation of the precursor of gelatinase A/72 kda type IV collagenase/MMP‐2 in lung carcinomas correlates with the expression of membrane‐type matrix metalloproteinase (MT‐MMP) and with lymph node metastasisInternational Journal of Cancer, 1995
- Plasma assay of gelatinase B:Tissue inhibitor of metalloproteinase complexes in cancerCancer, 1995
- Matrix Metalloproteinases and Their Inhibitors in Tumor ProgressionaAnnals of the New York Academy of Sciences, 1994
- A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodiesClinica Chimica Acta; International Journal of Clinical Chemistry, 1993